Intrachain disulphide bridges of rabbit immunoglobulin light chains of allotypes b4 and b5
Related Experiment Videos
The Biochemical Journal
|August 1, 1972
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Conformation as therapeutic target in the prionoses and other neurodegenerative conditions.
Methods in molecular medicine·2011
T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy.
Clinical and experimental immunology·2008
Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease.
Neuropathology and applied neurobiology·2008
Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study.
Neuropathology and applied neurobiology·2006
Genetic alterations of the BRI2 gene: familial British and Danish dementias.
Brain pathology (Zurich, Switzerland)·2006
Chromosome 13 dementias.
Cellular and molecular life sciences : CMLS·2005
Uncovering KRAS-mutant allele-specific biology and vulnerabilities in non-small cell lung cancer.
The Biochemical journal·2026
Sequence space exploration in SHP2: mechanistic insights from disease-associated mutations.
The Biochemical journal·2026
No lysine? No problem: the surprising roles of WNK kinases in physiology and disease.
The Biochemical journal·2026
CerS2-mediated lipotoxicity and calcium signaling: a novel sequential mechanism of apoptosis in cancer.
The Biochemical journal·2026
Recent advances in coarse-grained simulations of nucleic acid condensation.
The Biochemical journal·2026
Economic evaluation of PET-CT in staging and response assessment of patients with diffuse large B-cell lymphoma (DLBCL) in Thailand: a cost-utility analysis.
Cost effectiveness and resource allocation : C/E·2026
Serum Free Light Chains in Lymphoma: A Phenotype-First Framework for Biological Interpretation, Analytical Control, and Clinical Use.
Current oncology (Toronto, Ont.)·2026